This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Khosla, S. Articles by Riggs, B. L. Search for Related Content PubMed PubMed Citation Articles by Khosla, S. Articles by Riggs, B. L.

Estrogen and the Male Skeleton

Endocrine Research Unit (S.K., B.L.R.) and Department of Health Sciences Research (L.J.M.), Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905

Address all correspondence and requests for reprints to: Sundeep Khosla, M.D., Mayo Clinic, 200 First Street SW, 5-194 Joseph, Rochester, Minnesota 55905. E-mail: . khosla.sundeep{at}mayo.edu

Abstract

Because estrogen (E) and T are the major sex steroids in women and men, respectively, the traditional view had been that E primarily regulated bone turnover in women and T played the analogous role in men. The description of ER- deficient and aromatase-deficient males, however, initiated a major shift in our thinking on the relative roles of T and E in regulating the male skeleton, because these individuals all had unfused epiphyses, high bone turnover, and osteopenia. Similar, albeit less striking, findings were noted in mouse models with knock-out of either the ER- or the aromatase genes. Although these human experiments of nature and mouse knock-out models clearly demonstrated an important role for E in the growth and maturation of the male skeleton, they did not define the role of E vs. T in regulating the adult male skeleton. The past several years have witnessed an accumulation of evidence from observational as well as direct interventional studies that now clearly indicates that E plays a major, and likely dominant, role in bone metabolism in men. These data also suggest that a threshold level of bioavailable (or non-SHBG bound) E is needed for skeletal E sufficiency in the male, and that with aging, an increasing percentage of elderly men begin to fall below this level. It is this subset of men who may be at greatest risk for the development of age-related bone loss and osteoporosis. Moreover, these men may also be the ones most likely to respond favorably to treatment with selective E receptor modulators, or perhaps even to T replacement, because the skeletal effects of the latter may be mediated largely via aromatization to E.

This article has been cited by other articles:

				E.S. Orwoll, B.K.S. Chan, L.C. Lambert, L.M. Marshall, C. Lewis, and K.R. Phipps Sex Steroids, Periodontal Health, and Tooth Loss in Older Men Journal of Dental Research, August 1, 2009; 88(8): 704 - 708. [Abstract] [Full Text] [PDF]

				C. Ohlsson and L. Vandenput The role of estrogens for male bone health Eur. J. Endocrinol., June 1, 2009; 160(6): 883 - 889. [Abstract] [Full Text] [PDF]

				R. J. Santen, H. Brodie, E. R. Simpson, P. K. Siiteri, and A. Brodie History of Aromatase: Saga of an Important Biological Mediator and Therapeutic Target Endocr. Rev., June 1, 2009; 30(4): 343 - 375. [Abstract] [Full Text] [PDF]

				S. J. Jacobsen, T. C. Cheetham, R. Haque, J. M. Shi, and R. K. Loo Association Between 5-{alpha} Reductase Inhibition and Risk of Hip Fracture JAMA, October 8, 2008; 300(14): 1660 - 1664. [Abstract] [Full Text] [PDF]

				S. Khosla, S. Amin, and E. Orwoll Osteoporosis in Men Endocr. Rev., June 1, 2008; 29(4): 441 - 464. [Abstract] [Full Text] [PDF]

				E. Grundberg, K. Akesson, A. Kindmark, P. Gerdhem, A. Holmberg, D. Mellstrom, O. Ljunggren, E. Orwoll, H. Mallmin, C. Ohlsson, et al. The Impact of Estradiol on Bone Mineral Density Is Modulated by the Specific Estrogen Receptor-{alpha} Cofactor Retinoblastoma-Interacting Zinc Finger Protein-1 Insertion/Deletion Polymorphism J. Clin. Endocrinol. Metab., June 1, 2007; 92(6): 2300 - 2306. [Abstract] [Full Text] [PDF]

				D. S. Perrien, N. S. Akel, P. K. Edwards, A. A. Carver, M. S. Bendre, F. L. Swain, R. A. Skinner, W. R. Hogue, K. M. Nicks, T. M. Pierson, et al. Inhibin A Is an Endocrine Stimulator of Bone Mass and Strength Endocrinology, April 1, 2007; 148(4): 1654 - 1665. [Abstract] [Full Text] [PDF]

				S. Khosla Sex Hormone Binding Globulin: Inhibitor or Facilitator (or Both) of Sex Steroid Action? J. Clin. Endocrinol. Metab., December 1, 2006; 91(12): 4764 - 4766. [Full Text] [PDF]

				H. A. Fink, S. K. Ewing, K. E. Ensrud, E. Barrett-Connor, B. C. Taylor, J. A. Cauley, E. S. Orwoll, and for the Osteoporotic Fractures in Men Study Group Association of Testosterone and Estradiol Deficiency with Osteoporosis and Rapid Bone Loss in Older Men J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 3908 - 3915. [Abstract] [Full Text] [PDF]

				W. A. Bauman, A. M. Spungen, J. Wang, R. N. Pierson Jr., and E. Schwartz Relationship of fat mass and serum estradiol with lower extremity bone in persons with chronic spinal cord injury Am J Physiol Endocrinol Metab, June 1, 2006; 290(6): E1098 - E1103. [Abstract] [Full Text] [PDF]

				J. P. Bilezikian What's Good for the Goose's Skeleton is Good for the Gander's Skeleton. J. Clin. Endocrinol. Metab., April 1, 2006; 91(4): 1223 - 1225. [Full Text] [PDF]

				E. Orwoll, L. C. Lambert, L. M. Marshall, K. Phipps, J. Blank, E. Barrett-Connor, J. Cauley, K. Ensrud, S. Cummings, and for the Osteoporotic Fractures in Men Study Group Testosterone and Estradiol among Older Men J. Clin. Endocrinol. Metab., April 1, 2006; 91(4): 1336 - 1344. [Abstract] [Full Text] [PDF]

				H. Lee, J. S. Finkelstein, M. Miller, S. J. Comeaux, R. I. Cohen, and B. Z. Leder Effects of Selective Testosterone and Estradiol Withdrawal on Skeletal Sensitivity to Parathyroid Hormone in Men J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 1069 - 1075. [Abstract] [Full Text] [PDF]

				D. Vanderschueren, K. Venken, J. Ophoff, R. Bouillon, and S. Boonen Sex Steroids and the Periosteum--Reconsidering the Roles of Androgens and Estrogens in Periosteal Expansion J. Clin. Endocrinol. Metab., February 1, 2006; 91(2): 378 - 382. [Abstract] [Full Text] [PDF]

				S. L. Greenspan, P. Coates, S. M. Sereika, J. B. Nelson, D. L. Trump, and N. M. Resnick Bone Loss after Initiation of Androgen Deprivation Therapy in Patients with Prostate Cancer J. Clin. Endocrinol. Metab., December 1, 2005; 90(12): 6410 - 6417. [Abstract] [Full Text] [PDF]

				J. M. Kaufman and A. Vermeulen The Decline of Androgen Levels in Elderly Men and Its Clinical and Therapeutic Implications Endocr. Rev., October 1, 2005; 26(6): 833 - 876. [Abstract] [Full Text] [PDF]

				S. Khosla, B. L. Riggs, R. A. Robb, J. J. Camp, S. J. Achenbach, A. L. Oberg, P. A. Rouleau, and L. J. Melton III Relationship of Volumetric Bone Density and Structural Parameters at Different Skeletal Sites to Sex Steroid Levels in Women J. Clin. Endocrinol. Metab., September 1, 2005; 90(9): 5096 - 5103. [Abstract] [Full Text] [PDF]

				A.-M. Yu, K. Fukamachi, K. W. Krausz, C. Cheung, and F. J. Gonzalez Potential Role for Human Cytochrome P450 3A4 in Estradiol Homeostasis Endocrinology, July 1, 2005; 146(7): 2911 - 2919. [Abstract] [Full Text] [PDF]

				A. Aminorroaya, S. Kelleher, A. J Conway, L. P Ly, and D. J Handelsman Adequacy of androgen replacement influences bone density response to testosterone in androgen-deficient men Eur. J. Endocrinol., June 1, 2005; 152(6): 881 - 886. [Abstract] [Full Text] [PDF]

				L. Gennari, D. Merlotti, V. De Paola, A. Calabro, L. Becherini, G. Martini, and R. Nuti Estrogen Receptor Gene Polymorphisms and the Genetics of Osteoporosis: A HuGE Review Am. J. Epidemiol., February 15, 2005; 161(4): 307 - 320. [Abstract] [Full Text] [PDF]

				L. Gennari, R. Nuti, and J. P. Bilezikian Aromatase Activity and Bone Homeostasis in Men J. Clin. Endocrinol. Metab., December 1, 2004; 89(12): 5898 - 5907. [Abstract] [Full Text] [PDF]

				I. Van Pottelbergh, S. Goemaere, H. Zmierczak, and J. M. Kaufman Perturbed Sex Steroid Status in Men with Idiopathic Osteoporosis and Their Sons J. Clin. Endocrinol. Metab., October 1, 2004; 89(10): 4949 - 4953. [Abstract] [Full Text] [PDF]

				D. Vanderschueren, L. Vandenput, S. Boonen, M. K. Lindberg, R. Bouillon, and C. Ohlsson Androgens and Bone Endocr. Rev., June 1, 2004; 25(3): 389 - 425. [Abstract] [Full Text] [PDF]

				C. Meier, P. Y. Liu, L. P. Ly, J. de Winter-Modzelewski, M. Jimenez, D. J. Handelsman, and M. J. Seibel Recombinant Human Chorionic Gonadotropin But Not Dihydrotestosterone Alone Stimulates Osteoblastic Collagen Synthesis in Older Men with Partial Age-Related Androgen Deficiency J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 3033 - 3041. [Abstract] [Full Text] [PDF]

				C. Wang, G. Cunningham, A. Dobs, A. Iranmanesh, A. M. Matsumoto, P. J. Snyder, T. Weber, N. Berman, L. Hull, and R. S. Swerdloff Long-Term Testosterone Gel (AndroGel) Treatment Maintains Beneficial Effects on Sexual Function and Mood, Lean and Fat Mass, and Bone Mineral Density in Hypogonadal Men J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2085 - 2098. [Abstract] [Full Text] [PDF]

				S. Khosla, B. L. Riggs, E. J. Atkinson, A. L. Oberg, C. Mavilia, F. Del Monte, L. J. Melton III, and M. L. Brandi Relationship of Estrogen Receptor Genotypes to Bone Mineral Density and to Rates of Bone Loss in Men J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1808 - 1816. [Abstract] [Full Text] [PDF]

				U. I. L. Modder, A. Sanyal, A. E. Kearns, J. D. Sibonga, E. Nishihara, J. Xu, B. W. O'Malley, E. L. Ritman, B. L. Riggs, T. C. Spelsberg, et al. Effects of Loss of Steroid Receptor Coactivator-1 on the Skeletal Response to Estrogen in Mice Endocrinology, February 1, 2004; 145(2): 913 - 921. [Abstract] [Full Text] [PDF]

				W. M. Drake, D. L. Kendler, C. J. Rosen, and E. S. Orwoll An Investigation of the Predictors of Bone Mineral Density and Response to Therapy with Alendronate in Osteoporotic Men J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 5759 - 5765. [Abstract] [Full Text] [PDF]

				P. Szulc, B. Claustrat, F. Marchand, and P. D. Delmas Increased Risk of Falls and Increased Bone Resorption in Elderly Men with Partial Androgen Deficiency: The MINOS Study J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5240 - 5247. [Abstract] [Full Text] [PDF]

				L. Gennari, D. Merlotti, G. Martini, S. Gonnelli, B. Franci, S. Campagna, B. Lucani, N. Dal Canto, R. Valenti, C. Gennari, et al. Longitudinal Association between Sex Hormone Levels, Bone Loss, and Bone Turnover in Elderly Men J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5327 - 5333. [Abstract] [Full Text] [PDF]

				I. Van Pottelbergh, S. Goemaere, and J. M. Kaufman Bioavailable Estradiol and an Aromatase Gene Polymorphism Are Determinants of Bone Mineral Density Changes in Men over 70 Years of Age J. Clin. Endocrinol. Metab., July 1, 2003; 88(7): 3075 - 3081. [Abstract] [Full Text] [PDF]

				B. A. L. Crawford, P. Y. Liu, M. T. Kean, J. F. Bleasel, and D. J. Handelsman Randomized Placebo-Controlled Trial of Androgen Effects on Muscle and Bone in Men Requiring Long-Term Systemic Glucocorticoid Treatment J. Clin. Endocrinol. Metab., July 1, 2003; 88(7): 3167 - 3176. [Abstract] [Full Text] [PDF]

				R. A. Anderson, A. M. Wallace, N. Sattar, N. Kumar, and K. Sundaram Evidence for Tissue Selectivity of the Synthetic Androgen 7{alpha}-Methyl-19-Nortestosterone in Hypogonadal Men J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2784 - 2793. [Abstract] [Full Text] [PDF]

				L. C. Hofbauer, B. Allolio, and W. Arlt Dehydroepiandrosterone Supplementation in Elderly Men: The Role of Estrogens Versus Androgens on the Male Skeleton J. Clin. Endocrinol. Metab., August 1, 2002; 87(8): 4009 - 4009. [Full Text] [PDF]